metformin/retagliptin (HRX0701) / Jiangsu Hengrui Pharma - LARVOL DELTA

Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects (clinicaltrials.gov) - P1 | N=78 | Completed | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Dec 2022 ➔ Aug 2022 | Trial primary completion date: Dec 2022 ➔ Aug 2022

Trial completion • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus

Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects (clinicaltrials.gov) - P1 | N=78 | Active, not recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Recruiting ➔ Active, not recruiting

Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus

Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects (clinicaltrials.gov) - P1 | N=78 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting | N=120 ➔ 78

Enrollment change • Enrollment open • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus

Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects (clinicaltrials.gov) - P1 | N=120 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.

New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus